GREEN BAY, WI — Andrew Bartkowiak, a Hemophilia Outreach Center patient from Petoskey, became the first Michigan resident with hemophilia B to receive FDA-approved HEMGENIX gene therapy. His treatment offers new hope for fewer bleeds and freedom from regular infusions.
The Founding Story of Hemophilia Outreach Center
Caring, Sharing, and Learning TogetherLong before there was a center, a building, or even a formal program, there were two nurses in Green Bay who saw a need and stepped in to meet it. Peggy Maier and Audrey Nuskiewicz were both Registered Nurses working in Pediatrics...
